<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01458431</url>
  </required_header>
  <id_info>
    <org_study_id>MGR-LB-2010-01</org_study_id>
    <nct_id>NCT01458431</nct_id>
  </id_info>
  <brief_title>Levobupivacaine to the Surgical Wound Following Cesarean</brief_title>
  <official_title>Efficacy of Continuous Infusion of Levobupivacaine to the Surgical Wound Following Cesarean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Manuel Ángel Gómez-Ríos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Complexo Hospitalario Universitario de A Coruña</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The postoperative period following cesarean is associated with moderate to severe pain that
      requires a considerable amount of analgesics that carry with them side-effects such as
      nausea, vomiting, fatigue and immobilization. Several studies have tried, with variable
      results, to find a more effective analgesia alternative such as infusion of local anesthetics
      through a catheter in the surgical wound sinus, a practice that has currently been widely
      used in clinical practice. Despite existing references on its use in the postoperative period
      following cesareans there continues to be a lack of information on other aspects. The
      investigators study hypothesis is that the use of levobupivacaine in the surgical wound will
      reduce the surface of hyperalgesia compared to the control group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area of incisional secondary hyperalgesia</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain relief</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>consumption of morphine (mg) and paracetamol (gr)</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of chronic pain</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacokinetic variables of levobupivacaine</measure>
    <time_frame>72 hours</time_frame>
    <description>Cmax, Area Under Curve, Tmax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications and/or side effects related to the technique</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of satisfaction experienced by the patients through a survey</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>endocrin-metabolic response</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous levobupivacaine subfascial infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NaCl</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Continuous NaCl subfascial infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>continuous levobupivacaine subfascial infusion</description>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <other_name>local anesthetic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NaCl</intervention_name>
    <description>continuous NaCl subfascial infusion</description>
    <arm_group_label>NaCl</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Full-term pregnant women who undergo scheduled cesarean surgery under intradural
             anesthesia.

          -  Duly informed patients who have signed the informed consent during the preanesthesia
             consultation, or after a period of consideration if necessary, expressing their
             consent to be included in the study.

          -  Between 18-45 years of age.

          -  ASA I and II.

          -  Sufficient intellectual ability to understand the technique as well as the equipment
             being used.

        Exclusion Criteria:

          -  Failure to meet any of the above criteria.

          -  Presence of a major medical, cardiovascular, pulmonary, metabolic, renal or liver
             disorder.

          -  Preeclampsia and/or HELLP syndrome.

          -  Coagulopathy

          -  Profuse bleeding greater than 1000 ml or that which provokes hemodynamic instability
             that requires aggressive fluid therapy and/or transfusion.

          -  Allergy to any drug included in the protocol.

          -  Psychiatric or neurological pathology.

          -  Preexisting infection.

          -  Previous treatment with opioids or antidepressants or suffer from chronic pain.

          -  History of alcohol or drug abuse or known consumption of medications that interfere
             with LB metabolism.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuel Á gómez-Ríos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>C.H.U. A Coruña</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Teresa Herrera Hospital; A Coruña University Hospital Complex</name>
      <address>
        <city>A Coruña</city>
        <zip>15008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Møiniche S, Mikkelsen S, Wetterslev J, Dahl JB. A qualitative systematic review of incisional local anaesthesia for postoperative pain relief after abdominal operations. Br J Anaesth. 1998 Sep;81(3):377-83.</citation>
    <PMID>9861124</PMID>
  </reference>
  <reference>
    <citation>Mecklem DW, Humphrey MD, Hicks RW. Efficacy of bupivacaine delivered by wound catheter for post-Caesarean section analgesia. Aust N Z J Obstet Gynaecol. 1995 Nov;35(4):416-21.</citation>
    <PMID>8717568</PMID>
  </reference>
  <reference>
    <citation>Liu SS, Richman JM, Thirlby RC, Wu CL. Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials. J Am Coll Surg. 2006 Dec;203(6):914-32. Epub 2006 Oct 25. Review.</citation>
    <PMID>17116561</PMID>
  </reference>
  <reference>
    <citation>Lavand'homme PM, Roelants F, Waterloos H, De Kock MF. Postoperative analgesic effects of continuous wound infiltration with diclofenac after elective cesarean delivery. Anesthesiology. 2007 Jun;106(6):1220-5.</citation>
    <PMID>17525598</PMID>
  </reference>
  <reference>
    <citation>Ranta PO, Ala-Kokko TI, Kukkonen JE, Ohtonen PP, Raudaskoski TH, Reponen PK, Rawal N. Incisional and epidural analgesia after caesarean delivery: a prospective, placebo-controlled, randomised clinical study. Int J Obstet Anesth. 2006 Jul;15(3):189-94.</citation>
    <PMID>16798442</PMID>
  </reference>
  <reference>
    <citation>Zohar E, Shapiro A, Eidinov A, Fishman A, Fredman B. Postcesarean analgesia: the efficacy of bupivacaine wound instillation with and without supplemental diclofenac. J Clin Anesth. 2006 Sep;18(6):415-21.</citation>
    <PMID>16980157</PMID>
  </reference>
  <reference>
    <citation>Zohar E, Luban I, Zunser I, Shapiro A, Jedeikin R, Fredman B. Patient-controlled bupivacaine wound instillation following cesarean section: the lack of efficacy of adjuvant ketamine. J Clin Anesth. 2002 Nov;14(7):505-11.</citation>
    <PMID>12477585</PMID>
  </reference>
  <reference>
    <citation>Bamigboye AA, Hofmeyr GJ. Caesarean section wound infiltration with local anaesthesia for postoperative pain relief - any benefit? S Afr Med J. 2010 May 4;100(5):313-9. Review.</citation>
    <PMID>20460027</PMID>
  </reference>
  <reference>
    <citation>Bamigboye AA, Hofmeyr GJ. Local anaesthetic wound infiltration and abdominal nerves block during caesarean section for postoperative pain relief. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006954. doi: 10.1002/14651858.CD006954.pub2. Review.</citation>
    <PMID>19588413</PMID>
  </reference>
  <reference>
    <citation>Dahl JB, Møiniche S, Kehlet H. Wound infiltration with local anaesthetics for postoperative pain relief. Acta Anaesthesiol Scand. 1994 Jan;38(1):7-14. Review.</citation>
    <PMID>8140877</PMID>
  </reference>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2011</study_first_submitted>
  <study_first_submitted_qc>October 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2011</study_first_posted>
  <last_update_submitted>December 20, 2014</last_update_submitted>
  <last_update_submitted_qc>December 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Complexo Hospitalario Universitario de A Coruña</investigator_affiliation>
    <investigator_full_name>Manuel Ángel Gómez-Ríos</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>wound infusion</keyword>
  <keyword>Local anesthetic levobupivacaine</keyword>
  <keyword>Pain management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

